Spacelabs Looks To Pending CMS Decision To Boost U.S. ABPM Market
This article was originally published in The Gray Sheet
Executive Summary
Spacelabs Medical expects a positive upcoming reimbursement decision from CMS in October to boost U.S. sales of its Ultralite ambulatory blood pressure monitor (ABPM).